🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase one study to assess the safety of daily dosing of Lactobaci...
Status
Completed
Location
Community of Santa Clara
Start Date
2010-02
Trial ID
NCT00774163
Treatments Being Tested
Dyspepsia refers to chronic or recurrent upper gastrointestinal (GI) sympto...
Status
Recruiting
Location
KU Leuven
Start Date
2024-10-01
Trial ID
NCT06482671
Treatments Being Tested
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
The purpose of this study is to evaluate safety, tolerability, immunogenici...
Status
Completed
Location
CMAX Clinical Research
Start Date
2020-12-30
Trial ID
NCT05490017
The purpose of this study is to confirm the clinical efficacy and the safet...
Status
Completed
Location
Site #102
Start Date
2016-08-02
Trial ID
NCT03004469
Treatments Being Tested
The purpose of this research study is to test if an experimental drug calle...
Status
Withdrawn
Location
J. Edward Puzas
Start Date
2008-12
Trial ID
NCT00787358
The purpose of this study is to evaluate the clinical efficacy and safety o...
Status
Completed
Location
Multiple Locations
Start Date
2014-09
Trial ID
NCT02235272
The purpose of this study is to clinically evaluate the efficacy, safety as...
Status
Completed
Location
University of California Davis
Start Date
2014-10
Trial ID
NCT02601105
Treatments Being Tested
This is a phase II, double blind study with ZEP-3NA 0.1% or 1% vs. vehicle-...
Status
Unknown
Location
Ha'Emek MC
Start Date
2019-12-29
Trial ID
NCT04307862
Treatments Being Tested
In this early phase clinical research study, the investigational drug will ...
Status
Completed
Location
GEn1E-1124 Clinical Research Site
Start Date
2021-01-07
Trial ID
NCT04728061
Treatments Being Tested